Avinger announced full commercial launch of the Pantheris LV image-guided directional atherectomy system. With the initiation of full commercial launch, all current and prospective accounts can now order the Pantheris LV device, a line extension of the first and only image-guided atherectomy device for the treatment of peripheral artery disease. Prior to full commercialization, Avinger conducted a limited launch at 16 clinical centers in the United States, with over 20 interventional physicians treating patients with the new device. This initial clinical experience validated the key design enhancements incorporated into Pantheris LV, including higher speed plaque excision for efficient removal of challenging occlusive tissue, and multiple design elements to streamline user-operation. These new features include a proprietary jog mechanism for plaque apposition, an advanced guidewire management system, and design enhancements for improved tissue packing and removal.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AVGR:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue